IMMODULON
Live / Registered — Registered (as of 23 Nov 2021)
What this means for you
Registered since 23 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88354623
- Registration number
- 6564939
- Mark type
- Stylized text
- Filed
- 25 Mar 2019
- Published for opposition
- 15 Sept 2020
- Registered
- 23 Nov 2021
- Attorney of record
- Alexandra MacKay
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; immune modulators, namely, pharmaceutical preparations for treatment of immune system related diseases, disorders, and dysregulation; vitamins and vitamin preparations
- Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto, namely, research and development in the pharmaceutical and biotechnology fields; scientific and industrial analysis and research services, namely, research relating to immune system related diseases and disorders; clinical research in the field of medical science, namely, medical and scientific research in the nature of conducting clinical trials; research and development services in the fields of drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biological products, medical apparatus, devices and instruments, namely, pharmaceutical drug development services; supply of information in the area of laboratory technology, namely, providing technology information in the medical diagnostic industry; medical laboratory services; provision of scientific information via Internet portals, namely, providing scientific information regarding immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; scientific consultancy, namely, consulting services in the field of the research and development of immunotherapy products, namely, pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; consultancy and research in the fields of science and technology, namely, research in the pharmaceutical and biotechnology fields; laboratory analysis and diagnostic services, namely, laboratory services in the nature of analysis and diagnosis of immune dysregulation; technical consultation and research in the fields of biotechnology and drug discovery; product research and development; providing databases in the fields of science and technology, namely, providing an on-line computer database in the field of medical and scientific research of immune dysregulation
- Class 044 — Medical, beauty and agricultural services: Medical and therapeutic services, namely, treatment of patients with immuno disorders; medical, hygienic and beauty care for human beings; provision of medical information; advisory services relating to medical services, preparations and apparatus, namely, providing medical information, consultancy and advisory services; providing information and advice in the field of healthcare; providing databases and information in the field of health, namely, providing an on-line computer database featuring information regarding health and nutrition
Owner
- Immodulon Therapeutics Limited, London, GB
- Immodulon Therapeutics Limited, London, GB
- Immodulon Therapeutics Limited, London, GB
Prosecution history
- 23 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 19 Oct 2021 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 05 Oct 2021 — NOTICE OF ALLOWANCE CANCELLED
- 19 Oct 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Oct 2021 — TEAS DELETE 1(B) BASIS RECEIVED
- 04 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Apr 2021 — SOU EXTENSION 1 GRANTED
- 30 Apr 2021 — SOU EXTENSION 1 FILED
- 30 Apr 2021 — SOU TEAS EXTENSION RECEIVED
- 10 Nov 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Sept 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Sept 2020 — PUBLISHED FOR OPPOSITION
- 26 Aug 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Aug 2020 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 05 Aug 2020 — ASSIGNED TO LIE